There were 1,118 press releases posted in the last 24 hours and 412,515 in the last 365 days.

Global Pharmaceutical Drug Delivery Market Forecast to 2023: Rising Prevalence of Chronic Diseases / Growth in the Biologics Market / Technological Advancements and New Product Launches

Dublin, March 21, 2019 (GLOBE NEWSWIRE) -- The "Pharmaceutical Drug Delivery Market by Route and Application - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.

The global pharmaceutical drug delivery market is projected to reach USD 1,694.7 billion by 2023 from USD 1,244.4 billion in 2018, at a CAGR of 6.4% during the forecast period.

Growth in this market is mainly driven by the rising prevalence of chronic diseases, growth in the biologics market, and technological advancements and new product launches. On the other hand, the risk of needlestick injuries and the increasing pricing pressure are expected to challenge market growth in the coming years.

Drug delivery is the method or process of administration of a pharmaceutical drug to safely attain its desired therapeutic effect. Advancements in drug delivery technologies offer several benefits such as ease of use, convenience, and patient compliance. Drug developers are focusing on suitable delivery and packaging options for increasing the efficiency of drugs and proposing improved patient compliance.

The drug delivery technology market offers various growth opportunities for players due to factors such as increasing self-administration practices and home care drug delivery as well as the rising demand for biosimilars and generic drugs.

The major players in the drug delivery technology market are

  • 3M
  • Antares Pharma, Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights
4.1 Drug Delivery Technology: Market Overview
4.2 Drug Delivery Technology Market, By Route of Administration, 2018 Vs. 2023 (USD Billion)
4.3 Drug Delivery Technology Market, By Facility of Use, 2018-2023 (USD Billion)
4.4 Drug Delivery Technology Market Share, By Application and Region, 2018
4.5 Drug Delivery Technology Market: Geographic Growth Opportunities

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Rising Prevalence of Chronic Diseases
5.3.2 Growth in the Biologics Market
5.3.3 Technological Advancements and New Product Launches
5.4 Restraints
5.4.1 Risk of Needlestick Injuries
5.5 Opportunities
5.5.1 Self-Administration and Home Care
5.5.2 Rising Demand for Biosimilars
5.6 Challenges
5.6.1 Pricing Pressure

6 Drug Delivery Technology Market, By Route of Administration
6.1 Introduction
6.2 Oral Drug Delivery
6.2.1 Solid Oral Drugs
6.2.1.1 Tablets
6.2.1.2 Capsules
6.2.1.3 Powders
6.2.1.4 Pills
6.2.2 Liquid Oral Drugs
6.2.2.1 Syrups
6.2.2.2 Solutions
6.2.3 Semi-Solid Oral Drugs
6.2.3.1 Gels
6.2.3.2 Emulsions
6.2.3.3 Elixirs
6.3 Injectable Drug Delivery
6.3.1 Conventional Injection Devices
6.3.1.1 By Material
6.3.1.1.1 Glass
6.3.1.1.2 Plastic
6.3.1.2 By Product
6.3.1.2.1 Fillable Syringes
6.3.1.2.2 Prefilled Syringes
6.3.1.3 By Usability
6.3.1.3.1 Reusable Syringes
6.3.1.3.2 Disposable Syringes
6.3.2 Self-Injection Devices
6.3.2.1 Needle-Free Injectors
6.3.2.2 Autoinjectors
6.3.2.3 Pen Injectors
6.3.2.4 Wearable Injectors
6.3.3 Other Injector Devices
6.4 Topical Drug Delivery
6.4.1 Liquid Formulations
6.4.1.1 Solutions
6.4.1.2 Suspensions
6.4.2 Semi-Solid Formulations
6.4.2.1 Creams
6.4.2.2 Gels
6.4.2.3 Ointments
6.4.2.4 Pastes
6.4.2.5 Lotions
6.4.3 Solid Formulations
6.4.3.1 Suppositories
6.4.3.2 Powders
6.4.4 Transdermal Products
6.4.4.1 Transdermal Patches
6.4.4.2 Transdermal Gels
6.5 Ocular Drug Delivery
6.5.1 Liquid Formulations
6.5.1.1 Eye Drops
6.5.1.2 Liquid Sprays
6.5.2 Semi-Solid Formulations
6.5.2.1 Gels
6.5.2.2 Eye Ointments
6.5.3 Ocular Devices
6.5.3.1 Drug-Coated Contact Lenses
6.5.3.2 Ocular Inserts
6.6 Pulmonary Drug Delivery
6.6.1 Metered-Dose Inhalers
6.6.2 Dry Powder Inhalers
6.6.2.1 Dpi Drug Formulations are Chemically More Stable Than Their Counterparts Are
6.6.3 Nebulizers
6.6.3.1 Jet Nebulizers
6.6.3.2 Ultrasonic Nebulizers
6.6.3.3 Soft Mist Nebulizers
6.7 Nasal Drug Delivery
6.7.1 Nasal Drops
6.7.2 Nasal Sprays
6.7.3 Nasal Powders
6.7.4 Nasal Gels
6.8 Transmucosal Drug Delivery
6.8.1 Oral Formulations
6.8.2 Other Transmucosal Drug Delivery Technologies
6.9 Implantable Drug Delivery
6.9.1 Active Implantable Drug Delivery
6.9.2 Passive Implantable Drug Delivery

7 Drug Delivery Technology Market, By Patient Care Setting
7.1 Introduction
7.2 Hospitals
7.2.1 Hospitals Will Continue to Dominate the Drug Delivery Technology Market During the Forecast Period
7.3 Ambulatory Surgery Centers/Clinics
7.3.1 Increasing Preference for ASCS has Resulted in A Significant Rise in Demand for Drug Delivery Technologies
7.4 Home Care Settings
7.4.1 Home Care Settings to Register the Highest Growth Rate During the Forecast Period
7.5 Diagnostic Centers
7.5.1 Rising Prevalence of Chronic Diseases to Support Market Growth
7.6 Other Facilities of Use

8 Drug Delivery Technology Market, By Application
8.1 Introduction
8.2 Infectious Diseases
8.2.1 High Burden of Infectious Diseases Across the Globe to Drive Market Growth
8.3 Cancer
8.3.1 Cancer Forms A Key Therapeutic Application Segment for Drug Delivery Technologies
8.4 Cardiovascular Diseases
8.4.1 Increasing Prevalence of Cvds is Driving the Growth of the Drug Delivery Technology Market
8.5 Diabetes
8.5.1 Emergence of New Technologies is Supporting Market Growth
8.6 Respiratory Diseases
8.6.1 High Prevalence of Asthma & Copd to Drive the Adoption of Drug Delivery Technologies
8.7 Central Nervous System Disorders
8.7.1 Oral and Injectable Drug Delivery Systems are Widely Used in the Treatment of Cns Disorders
8.8 Autoimmune Diseases
8.8.1 Autoimmune Diseases Segment to Register the Highest Growth in the Forecast Period
8.9 Other Applications
8.9.1 Ophthalmic Disorders
8.9.2 Endocrine Disorders

9 Drug Delivery Technology Market, By Region

10 Competitive Landscape
10.1 Overview
10.2 Market Player Ranking, 2017
10.3 Competitive Scenario
10.4 Competitive Leadership Mapping (2017)
10.5 Competitive Leadership Mapping for Start-Ups (2017)

11 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/tn627n/global?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Delivery

22157.jpg